excisanin a has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, R; Feng, GK; Gao, YH; Li, DD; Tang, J; Wang, LL; Xia, LP; Zeng, YX; Zhou, WJ; Zhu, XF | 1 |
1 other study(ies) available for excisanin a and Hepatocellular Carcinoma
| Article | Year |
|---|---|
ExcisaninA, a diterpenoid compound purified from Isodon MacrocalyxinD, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of its signal pathway.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Diterpenes; Drugs, Chinese Herbal; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Isodon; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |